Full Text
Reality in Market Access In Germany and France – Comparative Analysis of Added Benefit Decisions on Innovative Pharmaceutical Therapies

Abstract

Authors

D. Droeschel A. Chicoye M. Lepretre

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×